02.26.14
Accriva Diagnostics, a hospital-based point-of-care cardiovascular diagnostics business, has appointed Scott Cramer as president and CEO.
Cramer has more than 30 years of commercial and operational excellence experience with medical device companies. He has held executive leadership positions for venture-backed companies throughout the cardiology, peripheral vascular and female health markets, including stints as president/CEO of Novasys Medical Inc. and president/CEO of Bacchus Vascular Inc.
Cramer has held top management positions in various healthcare companies, including senior vice president of U.S. Sales and Account Services for VNUS Medical Technologies, vice president of U.S. Sales at EndoSonics Corporation, national sales manager at Cardiometrics Inc., and several positions at Baxter Healthcare Corporation’s cardiovascular division. Cramer currently is executive chairman of NeuWave Medical and serves on the board of directors for Vascular Insights LLC, AccuVein LLC and Accriva. His also served on the boards of Venous Health, Bacchus Vascular Inc. and Novasys Medical Inc.
“We are pleased to welcome Scott to Accriva Diagnostics and look forward to his leadership,” said Joseph Nemmers, chairman of Accriva Diagnostics. “We are excited that Scott’s proven record of producing rapid growth and results across many medical device businesses will help Accriva.”
“I am very pleased to join Accriva Diagnostics at this critical juncture,” said Cramer. “This is an exciting time as we integrate ITC and Accumetrics to form Accriva Diagnostics. The combination of ITC's Hemochron and Accumetrics' VerifyNow product lines and numerous planned growth initiatives will create further value for our investors and our customers."
Piscataway, N.J.-based Accriva Diagnostics is the result of ITC’s 2013 acquisition of Accumetrics. The Accriva portfolio of products includes Hemochron, InRhythm and ProTime Microcoagulation systems; the VerifyNow system for assessment of platelet reactivity; IRMA TruPoint Blood Gas and Electrolyte systems; Avoximeter CO-Oximetry systems; and Tenderfoot, Tenderlett and Surgicutt skin incision products. Accriva is a portfolio company of Warburg Pincus, a global private equity firm.
Cramer has more than 30 years of commercial and operational excellence experience with medical device companies. He has held executive leadership positions for venture-backed companies throughout the cardiology, peripheral vascular and female health markets, including stints as president/CEO of Novasys Medical Inc. and president/CEO of Bacchus Vascular Inc.
Cramer has held top management positions in various healthcare companies, including senior vice president of U.S. Sales and Account Services for VNUS Medical Technologies, vice president of U.S. Sales at EndoSonics Corporation, national sales manager at Cardiometrics Inc., and several positions at Baxter Healthcare Corporation’s cardiovascular division. Cramer currently is executive chairman of NeuWave Medical and serves on the board of directors for Vascular Insights LLC, AccuVein LLC and Accriva. His also served on the boards of Venous Health, Bacchus Vascular Inc. and Novasys Medical Inc.
“We are pleased to welcome Scott to Accriva Diagnostics and look forward to his leadership,” said Joseph Nemmers, chairman of Accriva Diagnostics. “We are excited that Scott’s proven record of producing rapid growth and results across many medical device businesses will help Accriva.”
“I am very pleased to join Accriva Diagnostics at this critical juncture,” said Cramer. “This is an exciting time as we integrate ITC and Accumetrics to form Accriva Diagnostics. The combination of ITC's Hemochron and Accumetrics' VerifyNow product lines and numerous planned growth initiatives will create further value for our investors and our customers."
Piscataway, N.J.-based Accriva Diagnostics is the result of ITC’s 2013 acquisition of Accumetrics. The Accriva portfolio of products includes Hemochron, InRhythm and ProTime Microcoagulation systems; the VerifyNow system for assessment of platelet reactivity; IRMA TruPoint Blood Gas and Electrolyte systems; Avoximeter CO-Oximetry systems; and Tenderfoot, Tenderlett and Surgicutt skin incision products. Accriva is a portfolio company of Warburg Pincus, a global private equity firm.